PATENT CLAIM ANALYSIS

Application Number: 16286216
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "266000"]

Abstract:
Described herein are crystalline forms of Compound 1 useful for the prevention and treatment of angiogenic ocular conditions; methods of treating a disease comprising; processes for preparing; and kits comprising, the same.

Claim (Index 3):
The method of  claim 1 , wherein the pharmaceutical composition is suitable for topical administration.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 99.0
- Lexical Diversity: 1.27586
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15694331', '15694383', '15694252', '15529969', '14530092']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7755476489413714
- 35 USC 102 Novelty (BERT): 0.4937372545373357
- Combined Prediction Score: 0.7473666095009678
- Mean Citation Score: 229.016342
- Max Citation Score: 238.3421
- Similarity Product: 183.0715101716876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test